高效价猪圆环病毒Ⅱ型Cap蛋白多克隆抗体的制备及应用

猪圆环病毒(Porcine circovirus,PCV)衣壳蛋白(Capsid protein,Cap)是病毒主要的抗原蛋白,在病毒感染和宿主免疫应答中起重要作用。为了制备抗PCV2b Cap蛋白的高效价多克隆抗体,利用大肠杆菌表达系统对不含核定位信号肽的PCV2b Cap进行了原核表达,获得了可溶性重组蛋白。将纯化后的重组蛋白免疫新西兰白兔,制备抗血清,并进一步以辛酸-硫酸铵沉淀法提纯IgG。ELISA检测显示所制备抗体效价可达到1∶10~7,表明抗体具有较高效价。应用该抗体对人工感染PCV2b的PK-15细胞、小鼠组织进行了免疫印迹、间接免疫荧光和免疫组织化学检测,结果表明该抗体在多种检测方法中均能与目的抗原发生特异性结合。该研究制备的高效价抗体为PCV2b的临床检测及科学研究提供了候选工具。     

寨卡病毒NS2B蛋白的表达纯化及单克隆抗体制备

目的:应用大肠杆菌重组表达并纯化寨卡病毒NS2B蛋白,制备抗NS2B蛋白的单克隆抗体。方法:构建携带NS2B基因的重组原核表达质粒,采用大肠杆菌ER2566作为表达菌株,以IPTG诱导表达,通过亲和层析纯化获得NS2B目的蛋白。用纯化后的NS2B蛋白免疫BALB/c小鼠,筛选制备抗NS2B蛋白的单克隆抗体,并初步分析抗体的反应活性和特异性。结果:表达并纯化获得寨卡病毒NS2B蛋白,筛选获得可与NS2B蛋白结合并具有较好反应活性的单克隆抗体2H11,该单抗可识别寨卡病毒感染细胞后表达的NS2B蛋白。结论:筛选获得靶向寨卡病毒NS2B蛋白的单克隆抗体,可为后期深入开展寨卡病毒NS2B蛋白的功能和相关抗病毒药物研究提供支持。     

表达猪圆环病毒Ⅱ型ORF2基因的重组猪伪狂犬病病毒的免疫原性

【目的】为研制预防猪圆环病毒II型(PCV2)感染的重组伪狂犬病病毒(PRV)活载体疫苗。【方法】将PCV2 ORF2基因插入到PRV通用载体pG中,利用脂质体LipofectamineTM2000试剂盒将重组转移质粒pGO与猪PRV弱毒HB98株DNA共转染猪睾丸(ST)细胞,通过3轮蚀斑纯化重组病毒。将重组病毒、商品化PCV2灭活苗及DMEM培养液分别免疫6周龄雌性昆明小鼠,4周后加强免疫1次,首免后第8周用PCV2强毒NY株对小鼠进行攻毒。【结果】成功获得表达ORF2基因的重组病毒PGO,首免重组病毒后小鼠体内抗PCV2的ELISA抗体水平很低,二免后小鼠PCV2特异的ELISA抗体水平明显升高,并且重组病毒组能够激发PCV2特异的淋巴细胞增殖效应。攻毒试验表明重组病毒组和PCV2灭活疫苗组均能有效抵抗PCV2强毒攻击。【结论】表明表达ORF2基因的重组病毒PGO具有良好免疫原性。     

猪瘟病毒衣壳蛋白靶向核酸酶表达系统的建立及鉴定

根据猪瘟病毒衣壳蛋白(C)基因序列设计一对引物,RT-PCR扩增获得编码猪瘟病毒衣壳蛋白的C基因,将其插入到含有葡萄球菌核酸酶(SN)基因的真核表达载体pcDNA-SN中,筛选获得重组质粒pcDNA-C-SN。脂质体转染猪肾细胞(PK-15),并经G418稳定筛选,通过RT-PCR、免疫印迹和间接免疫荧光鉴定表达的融合蛋白,体外DNA消化试验检测核酸酶活性。结果表明融合蛋白C-SN在PK-15细胞中获得了稳定表达,能够被兔抗猪瘟病毒衣壳蛋白多抗所识别,并具有良好的核酸酶活性,能够对DNA进行切割。同时,稳定表达融合蛋白C-SN的PK-15细胞系中能够有效抑制猪瘟野毒的增殖,使其感染性降低102～103倍。这些结果为进一步将衣壳蛋白靶向病毒灭活策略应用于抵抗猪瘟病毒感染奠定了基础。     

登革病毒衣壳蛋白靶向核酸酶表达系统的建立及应用

根据登革 2型病毒衣壳蛋白C基因和葡萄球菌核酸酶SN基因序列设计引物 ,从构建的原核表达载体pLEX D2C SN中扩增获得编码登革病毒衣壳蛋白和葡萄球菌核酸酶的融合基因D2C SN ,将其插入到真核表达载体pcDNA6 V5 His中 ,筛选获得重组质粒pcDNA D2C SN .电穿孔转染BHK细胞后 ,5mg Lblasticidin压力筛选 ,通过RT PCR、间接免疫荧光和免疫印迹鉴定表达的蛋白 ,体外DNA消化试验检测核酸酶活性 .结果表明 ,融合蛋白D2C SN在BHK细胞中获得了稳定表达 ,表达的融合蛋白能够被抗登革病毒衣壳蛋白的单克隆抗体特异识别 ,并具有良好的核酸酶活性 ,能够对DNA进行切割 .同时 ,BHK细胞中稳定表达的融合蛋白D2C SN能够有效抑制登革病毒的增殖 ,使其感染性降低 10 3 ～ 10 4倍 .这些结果为进一步将衣壳蛋白靶向病毒灭活策略应用于人类抗登革病毒感染奠定了基础     

牛免疫缺陷病毒基质蛋白和衣壳蛋白的可溶性表达

基质蛋白和衣壳蛋白是BIV的主要结构蛋白,在病毒感染及整个复制周期中起重要作用.本文采用pTXB系统在大肠杆菌中表达出融合状态的牛免疫缺陷病毒BIV基质蛋白MA及衣壳蛋白CA,经几丁质亲合、自剪切纯化后,获得不含融合片段的纯化产物.每克湿菌体MA产量可达毫克级,CA表达量达十毫克级.用原核表达获得的高纯度CA蛋白免疫大白兔获得的抗血清,经Western Blot分析显示能够与病毒颗粒的CA蛋白发生特异反应,证实表达产物具有良好的免疫原性和反应原性,可用于制备相应抗体,为研究BIV相应基因表达变化,进行体外蛋白质相互作用试验提供工具.     

牛免疫缺陷病毒基质蛋白和衣壳蛋白的可溶性表达

基质蛋白和衣壳蛋白是BIV的主要结构蛋白,在病毒感染及整个复制周期中起重要作用。本文采用 pTXB系统在大肠杆菌中表达出融合状态的牛免疫缺陷病毒 BIV基质蛋白 MA及衣壳蛋白 CA,经几丁质亲合、自剪切纯化后,获得不含融合片段的纯化产物。每克湿菌体MA产量可达毫克级,CA表达量达十毫克级。用原核表达获得的高纯度CA蛋白免疫大白兔获得的抗血清,经Western Blot 分析显示能够与病毒颗粒的 CA蛋白发生特异反应,证实表达产物具有良好的免疫原性和反应原性,可用于制备相应抗体,为研究 BIV相应基因表达变化,进行体外蛋白质相互作用试验提供工具。     

表达猪圆环病毒II型ORF2基因的重组猪伪狂犬病病毒的免疫原性

摘要:【目的】为研制预防猪圆环病毒II型(PCV2)感染的重组伪狂犬病病毒(PRV)活载体疫苗。【方法】将PCV2 ORF2基因插入到PRV通用载体pG中,利用脂质体LipofectamineTM 2000试剂盒将重组转移质粒pGO与猪PRV弱毒HB98株DNA共转染猪睾丸(ST)细胞,通过3轮蚀斑纯化重组病毒。将重组病毒、商品化PCV2灭活苗及DMEM培养液分别免疫6周龄雌性昆明小鼠,4周后加强免疫1次,首免后第8周用PCV2强毒NY株对小鼠进行攻毒。【结果】成功获得表达ORF2基因的重组病毒PGO,首免重组病毒后小 鼠体内抗PCV2的ELISA抗体水平很低,二免后小鼠PCV2特异的ELISA抗体水平明显升高,并且重组病毒组能够激发PCV2特异的淋巴细胞增殖效应。攻毒试验表明重组病毒组和PCV2灭活疫苗组均能有效抵抗PCV2强毒攻击。【结论】表明表达ORF2基因的重组病毒PGO具有良好免疫原性。     

猪圆环病毒2型Cap蛋白多克隆抗体的制备及鉴定

旨在制备猪圆环病毒2型(PCV2)Cap蛋白的多克隆抗体。以PCV2毒株(CAU0673)DNA为模板进行PCR,扩增目的片段大小约为702 bp,构建pET30a-PCV2-Cap重组质粒,转入大肠杆菌BL21(DE3),IPTG诱导表达;对目的蛋白进行NiNTA树脂亲和层析纯化、复性,并进行SDS-PAGE和Western blot鉴定;将纯化后的重组Cap蛋白与弗氏佐剂混匀乳化,经背部皮下多点注射4次,免疫新西兰大耳白兔,制备成兔抗Cap蛋白多克隆抗体,采用Western blot和间接免疫荧光试验(IFA)验证兔抗血清特异性,并用间接ELISA测定抗血清抗体效价。PCR、双酶切和测序鉴定结果表明,重组质粒pET30a-PCV2-Cap构建正确;重组Cap蛋白以包涵体的形式表达,大小约为34 kD,复性后重组Cap蛋白可与PCV2阳性猪血清发生特异性反应;制备的多克隆抗体与PCV2重组Cap蛋白和全病毒抗原均可发生反应,ELISA抗体效价 1∶12 800,显著高于商品化疫苗组。     

猪Ⅱ型圆环病毒ORF2与猪GM-CSF基因重组腺病毒共表达及免疫效果分析

旨在构建含融合基因pGMCSF-ORF2的重组腺病毒,并对其表达水平和免疫效果进行分析.运用PCR方法扩增PCV2 ORF2和pGM-CSF基因,拼接后克隆入pMD18-T载体,然后再亚克隆入腺病毒穿梭质粒pShuttle-CMV中,阳性穿梭质粒经PmeⅠ酶线性化后电转化含腺病毒基因组(AdEasy-1)的大肠杆菌细胞BJ5183-Ad-1,成功获得了重组腺病毒DNA.将纯化后的重组腺病毒DNA转染AD293细胞,经过病毒基因组的PCR和转录水平的RT-PCR及Western blot等方面对融合蛋白的表达进行了鉴定.以该病毒免疫Babl/c小白鼠,对免疫小鼠血清中PCV2抗体进行检测.结果显示,获得了pGMCSF-ORF2重组基因,重组腺病毒载体构建成功,获得了表达pGMCSF-ORF2融合蛋白的重组腺病毒.该病毒免疫小鼠后,在小鼠血清中检测到了PCV2的特异性抗体.获得的重组腺病毒能有效表达pGMCSF-ORF2融合蛋白,且可诱导小鼠产生针对PCV2的特异性抗体.     

In vitro expression, monoclonal antibody and bioactivity for capsid protein of porcine circovirus type II without nuclear localization signal

We expressed firstly the Capsid protein gene defecting the nuclear localization signal (NLS) of Porcine circovirus type II (PCV2) in Escherichia coli as a fusion protein with glutathione S-transferase (rGST-dCap protein). The purified rGST-dCap protein and the recombinant NLS-defected Cap protein of PCV2 (rdCap protein) from the purified rGST-dCap protein reacted specifically with swine antiserum to PCV2. Furthermore, the obtained monoclonal antibodies (mAbs) to rdCap protein were shown to bind to PCV2 particles replicated in PK15 cell and capsid protein (Cap protein) of PCV2 expressed in PK15 cells, respectively. mAbs to rdCap protein also revealed the neutralizing ability to PCV2 particles. These results demonstrated that rGST-dCap protein expressed in E. coli was folded correctly or at least partly, and mAbs to rdCap protein possessed the binding epitopes of PCV2 particles whereas mAbs 4C4 and 3F6 to rdCap protein remained the neutralization epitope of PCV2 particle, showing a possibility of neutralizing mAb to rdCap protein as an immnuotherapeutic agent and a potential of rGST-dCap protein as a vaccine antigen or serodiagnostic reagent.     

A Cucumber Mosaic Virus Based Expression System for the Production of Porcine Circovirus Specific Vaccines

Potential porcine circovirus type 2 (PCV2) capsid protein epitopes, suitable for expression on the surface of cucumber mosaic virus (CMV) particles were determined by a thorough analysis of the predicted PCV capsid protein structure. The ab initio protein structure prediction was carried out with fold recognition and threading methods. The putative PCV epitopes were selected on the basis of PCV virion models and integrated into the plant virus coat protein, after amino acid position 131. The recombinants were tested for infectivity and stability on different Nicotiana species and stable recombinant virus particles were purified. The particles were tested for their ability to bind to PCV induced porcine antibodies and used for specific antibody induction in mice and pigs. The results showed that PCV epitopes expressed on the CMV surface were recognized by the porcine antibodies and they were also able to induce PCV specific antibody response. Challenge experiment with PCV2 carried out in immunized pigs showed partial protection against the infection. Based on these results it was concluded that specific antiviral vaccine production for the given pathogen was feasible, offering an inexpensive way for the mass production of such vaccines.     

Preparation and epitope characterization of monoclonal antibodies against firefly luciferase

The 6-His tagged firefly luciferase was highly expressed in E. coli and purified to homogeneity by affinity chromatography and gel filtration. After immunizing Balb/c mice with the antigen, 6 hybridomas clones were found to secrete monoelonal antibodies (mAbs) and the mAbs were also purified separately. The competitive binding experiments show that 2 mAbs can bind heat-denatured antigen or its proteolytic fragments but not the native lueiferase, suggesting that their epitopes might be accommodated in the internal segments of the protein. On the other hand, the other 4 mAbs are capable of binding both native and denatured antigens. It infers that their epitopes locate in the segments on the protein surface. The results also suggest that the six mAbs are all sequence-specific.     

Preparation and epitope characterization of monoclonal antibodies against firefly luciferase

The 6-His tagged firefly luciferase was highly expressed inE. coli and purified to homogeneity by affinity chromatography and gel filtration. After immunizing Balb/c mice with the antigen, 6 hybridomas clones were found to secrete monoclonal antibodies (mAbs) and the mAbs were also purified separately. The competitive binding experiments show that 2 mAbs can bind heat-denatured antigen or its proteolytic fragments but not the native luciferase, suggesting that their epitopes might be accommodated in the internal segments of the protein. On the other hand, the other 4 mAbs are capable of binding both native and denatured antigens. It infers that their epitopes locate in the segments on the protein surface. The results also suggest that the six mAbs are all sequence-specific.     

In vitro expression and monoclonal antibody of RNA-dependent RNA polymerase for infectious bursal disease virus

VP1, the RNA-dependent RNA polymerase of infectious bursal disease virus (IBDV), has been suggested to play an essential role in the replication and translation of viral RNAs. In this study, we first expressed the complete VP1 protein gene in Escherichia coli (E. coli), and then the produced polyclonal antibody and four monoclonal antibodies (mAbs) to recombinant VP1 protein (rVP1) were shown to bind the IBDV particles in chicken embryo fibroblast and Vero cells. The epitopic analysis showed that mAbs 1D4 and 3C7 recognized respectively two distinct antigenic epitopes on the rVP1 protein, but two pair of mAbs 1A2/2A12 and 1E1/1H3 potentially recognized another two topologically related epitopes. Immunocytochemical stainings showed that VP1 protein formed irregularly shaped particles in the cytoplasm of the IBDV-infected cells. These results demonstrated that the mAbs to rVP1 protein could bind the epitopes of IBDV particles, indicating that the rVP1 protein expressed in E. coli was suitable for producing the mAb to VP1 protein of IBDV, and that the cytoplasm could be the crucial site for viral genome replication of IBDV.     

猪圆环病毒2型(PCV2)核衣壳蛋白免疫原性的鉴定和应用及其多抗在PCV2感染诊断中的应用

猪圆环病毒2型ORF2编码与病毒毒力相关的结构蛋白--核衣壳蛋白(Cap),该蛋白可以用于PCV2感染的血清学调查,但不同区域的PCV2分离株的ORF2特别是其抗原表位序列存在一定的突变.本研究将PCV2浙江分离株ORF2的主要抗原表位以及PCV1 ORF2进行了原核表达,将分别纯化的融合蛋白Cap2s和Cap1s免疫SPF兔后制备多抗,并进一步分析了纯化蛋白的免疫原性和多抗的特性.Western blot结果表明无论Cap2s和Cap1s均能与两个多抗发生交叉反应,而PCV2或PCV1阳性猪血清只能分别特异性地识别Cap2s和Cap1s.IFA结果则证明两个多抗对于天然Cap蛋白无交叉反应性.利用Cap2s作为包被抗原对13个猪场的259份血清样品的PCV2抗体进行ELISA检测,平均阳性率为80.69%(209/259),而各猪场的阳性率差异较大(48.28%～100%).以上结果表明Cap2s可作为一个型特异性抗原用于浙江省本地猪场猪群血清中PCV2抗体的监控,而其多抗也可用于免疫组化对PCV2感染进行有效诊断.     

猪圆环病毒2型ORF2基因在昆虫细胞中的表达及其特性

利用Bac-to-Bac杆状病毒表达系统将圆环病毒2型的ORF2全基因克隆到杆状病毒转移载体pFastBac^TM1中,获得重组转移载体pFast-OFR2,再将其转化进含穿梭载体Bacmid的感受态细胞DH10Bac中,发生转座作用,经蓝白菌落筛选得到含ORF2基因的重组穿梭载体Bac-ORF2,以脂质体介导的方法将重组穿梭载体转染sf9细胞,获得重组病毒,命名为Ac-ORF2。间接免疫荧光分析表明,PCV2阳性血清能使Ac-ORF2感染的sf9昆虫细胞呈强的荧光着色; SDS-PAGE与Western-blotting分析可见大小约为28kD的特异性带,表明Ac.ORF2在sf9细胞中成功表达了PCV2-ORF2蛋白。将该表达蛋白纯化并经磷钨酸负染后,通过电镜观察可见形态与PCV2病毒粒子相似的病毒样颗粒(VLPs),其中某些颗粒由于中心浓染而似空衣壳,其直径也为17nm左右。     

Virus-like particles of recombinant PCV2b carrying FMDV-VP1 epitopes induce both anti-PCV and anti-FMDV antibody responses

Mixed infection of porcine circovirus type 2 (PCV2) and foot-and-mouth disease virus (FMDV) is devastating to swine populations. To develop an effective vaccine that can protect the pigs from the infection of PCV2 and FMDV, we used the neutralizing B cell epitope region (aa 135–160) of FMDV to replace the regions aa 123–151 and aa 169–194 of the PCV2b Cap protein to generate a recombinant protein designated as Capfb. The Capfb protein was expressed in Escherichia coli system and the purified Capfb protein assembled into virus-like particles (VLPs) through dialysis. The ability of the Capfb protein to induce effective immune response against FMDV and PCV2b was tested in mice and guinea pigs. The results showed that the Capfb-VLPs could elicit anti-PCV2b and anti-FMDV antibody response in mice and guinea pigs without inducing antibodies against decoy epitope. Moreover, the Capfb-VLPs could enhance the percentage and activation of B cells in lymph nodes when the mice were stimulated with inactivated FMDV or PCV2b. These data suggested that the Capfb-VLPs could be an efficacious candidate antigen for developing a novel PCV2b-FMDV bivalent vaccine.

     

Localization of conserved B-cell epitopes among encapsulated and non-encapsulated Haemophilus influenzae P2 porin proteins using synthetic peptides.

The P2 outer membrane protein of Haemophilus influenzae belongs to a class of apparently ubiquitous proteins in Gram-negative bacteria that function as porins. Murine hybridomas raised to the P2 protein and synthetic peptides were used to investigate the structural and antigenic relationships among P2 proteins of encapsulated and non-encapsulated H. influenzae. Three monoclonal antibodies (mAbs), P2-17, P2-18 and P2-19, recognizing epitopes on the P2 protein, as shown by Western immunoblotting of outer membrane preparations, and purified and recombinant P2 proteins are described. The epitopes reactive with the mAbs were widely distributed among H. influenzae strains since 70-100% of strains of encapsulated and non-encapsulated isolates collected worldwide were recognized by individual mAbs. None of the mAbs reacted with H. parainfluenzae or other bacterial species. The peptide composition of P2 epitopes was determined by analysis of mAb reactivity with a series of overlapping synthetic peptides that covered the amino acid sequences of H. influenzae type b. The domains recognized by these mAbs were completely distinct. mAb P2-18, reactive with an epitope conserved among all H. influenzae P2 porin molecules which were screened, recognized a peptide corresponding to the N-terminal segment (residues 1-14). The P2-17- and P2-19-specific epitopes were located between residues 28 and 55, and 101 and 129, respectively. None of the epitopes were exposed on the cell surface since no mAbs bound to intact live bacteria.(ABSTRACT TRUNCATED AT 250 WORDS)     

Immunodominance of conformation-dependent B-cell epitopes of protein antigens

Immunodominance of conformational epitopes over linear ones in four proteins was quantified making use of the B-cell hybridoma technology. The proteins were immunized in their native forms into BALB/c mice, and clonal frequencies of B-cell hybridomas that produce antibodies to the native and denatured forms were determined, using ELISA and immunoblotting. All 16 monoclonal antibodies (mAbs) to Porphyromonas gingivalis fimbria were suggested to recognize conformational epitopes expressed by the oligomer. Ten out of 14 mAbs to Serratia marcescens fimbria and 13 of 15 mAbs to hen lysozyme were also specific to their conformational epitopes. In contrast, all 18 mAbs to a surface protein of Streptococcus mutans, termed PAc, reacted to both the native and denatured forms, thereby indicating the immunodominance of linear epitopes in this protein. The results suggest that B-cell epitopes of proteins possessing stable tertiary or quaternary structures are predominantly expressed by the higher-order structures.